169 related articles for article (PubMed ID: 28607365)
21. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer.
Kawaguchi K; Suzuki E; Yamaguchi A; Yamamoto M; Morita S; Toi M
Breast Cancer; 2017 Jan; 24(1):111-120. PubMed ID: 26942414
[TBL] [Abstract][Full Text] [Related]
23. Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
Chaudhary B; Elkord E
Expert Opin Ther Targets; 2015 Feb; 19(2):147-61. PubMed ID: 25351619
[TBL] [Abstract][Full Text] [Related]
24. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
25. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
Mishra S; Srivastava AK; Suman S; Kumar V; Shukla Y
Cancer Lett; 2015 Dec; 369(1):67-75. PubMed ID: 26276721
[TBL] [Abstract][Full Text] [Related]
26. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
[TBL] [Abstract][Full Text] [Related]
27. High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma.
Ben Q; Zheng J; Fei J; An W; Li P; Li Z; Yuan Y
Pancreas; 2014 Jul; 43(5):744-9. PubMed ID: 24632553
[TBL] [Abstract][Full Text] [Related]
28. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
[TBL] [Abstract][Full Text] [Related]
29. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
30. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
31. Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment.
Vilsmaier T; Rack B; Janni W; Jeschke U; Weissenbacher T;
BMC Cancer; 2016 Jul; 16():547. PubMed ID: 27464822
[TBL] [Abstract][Full Text] [Related]
32. A dual prognostic role for the TGFβ receptors in human breast cancer.
Hachim IY; Hachim MY; López-Ozuna VM; Ali S; Lebrun JJ
Hum Pathol; 2016 Nov; 57():140-151. PubMed ID: 27445263
[TBL] [Abstract][Full Text] [Related]
33. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
[TBL] [Abstract][Full Text] [Related]
34. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
[TBL] [Abstract][Full Text] [Related]
35. NRP-1 expression is strongly associated with the progression of pituitary adenomas.
Lee SW; Lee JE; Yoo CY; Ko MS; Park CS; Yang SH
Oncol Rep; 2014 Oct; 32(4):1537-42. PubMed ID: 25109698
[TBL] [Abstract][Full Text] [Related]
36. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
37. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
[TBL] [Abstract][Full Text] [Related]
38. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer.
Zeng Z; Chen X; Zhu D; Luo Z; Yang M
Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980
[TBL] [Abstract][Full Text] [Related]
39. Gene profiling and circulating tumor cells as biomarker to prognostic of patients with locoregional breast cancer.
Kuniyoshi RK; Gehrke Fde S; Alves BC; Vilas-Bôas V; Coló AE; Sousa N; Nunes J; Fonseca FL; Del Giglio A
Tumour Biol; 2015 Sep; 36(10):8075-83. PubMed ID: 25976504
[TBL] [Abstract][Full Text] [Related]
40. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
